Marksans Pharma Ltd.: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

Particulars	Mar-25	Jun-25	Sep-25	Dec-25	Mar-26
Revenue	71	620	720	754	856
Other income	2	6	22	20	35
Expenses	61	549	609	624	691
Cost of materials consumed	19	193	228	274	265
Purchases of stock-in-trade	16	172	106	27	150
Change in inventories	-2	-102	-25	15	-24
Employee benefit expense	10	98	104	112	107
Finance costs	0.30	6	6	6	6
Depreciation & amortisation	2	23	27	24	24
Other expenses	16	160	164	165	163
EBITDA	14	106	166	181	231
EBIT	12	83	139	157	206
Profit Before Tax	12	77	133	151	200
Tax expense	3	18	34	37	51
Deferred tax	0.10	-1	-2	-3	-7
Net Profit	9	58	99	114	149
Financial Ratios
Operating Profit Margin	16.81%	13.34%	19.28%	20.81%	24.10%
EBITDA Margin	20.06%	17.06%	23.01%	24.03%	26.94%
Net Profit Margin	12.85%	9.39%	13.76%	15.12%	17.41%
Earnings Per Share (₹)	2.00	1.29	2.17	2.50	3.27

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.